Diagnostyka S.A. (WSE:DIA)
163.10
0.00 (0.00%)
Last updated: May 27, 2026, 12:21 PM CET
Diagnostyka Company Description
Diagnostyka S.A. provides diagnostic services in Poland.
The company operates as a medical laboratory, which offers services, such as ultrasound, X-ray, computed tomography, and magnetic resonance imaging.
It also offers specialized research in the field of microbiology, autoimmunity, toxicology, and molecular biology, as well as human genome research, histopathological examinations, immunohistochemical tests, cytological tests, and cytogenetic tests.
The company provides services to individual clients, and public and private entities. Diagnostyka S.A. was founded in 1998 and is headquartered in Kraków, Poland.
Diagnostyka S.A.
| Country | Poland |
| Founded | 1998 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 8,645 |
| CEO | Jakub Swadzba |
Contact Details
Address: Ul. Prof. Michala Zyczkowskiego 16 Kraków, 31-864 Poland | |
| Phone | 48 12 295 0100 |
| Website | diag.pl |
Stock Details
| Ticker Symbol | DIA |
| Exchange | Warsaw Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PLN |
| ISIN Number | PLDGNST00012 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| Jakub Swadzba | President of the Management Board and Chief Executive Officer |
| Pawel Chytla | Vice President of the Management Board and VP of Finance |
| Marta Rogalska-Kupiec | Vice-President of the Management Board and Chief Operating Officer |
| Dariusz Zowczak | Chief Sales Officer and Vice-President of the Management Board |
| Jaromir Pelczarski | Vice-President of the Management Board and Chief Transformation Officer |